Citation
85 FR 328
Multiple canonical documents share this first-page citation.
- Prospective Grant of an Exclusive Patent License: Development and Commercialization of CD19/CD22 Chimeric Antigen Receptor (CAR) Therapies for the Treatment of B-Cell Malignancies Friday, January 3, 2020 85 FR 328
- Center for Scientific Review; Notice of Closed Meetings Friday, January 3, 2020 85 FR 328
- Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings Friday, January 3, 2020 85 FR 328